A potential risk of sublingual nifedipine treatment in surgically treated patients in Japan.
Kobayashi
E
E
Kitoh
Y
Y
Fujimura
A
A
D000286:Administration, Sublingual; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D002983:Clinical Competence; D006801:Humans; D007564:Japan; D017202:Myocardial Ischemia / Q000139:chemically induced*; D009543:Nifedipine / Q000008:administration & dosage / Q000009:adverse effects*
D002121:Calcium Channel Blockers; D009543:Nifedipine